Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of CMV retinitis in HIV infected patients.

× No keyword cloud information.

17 in total

1. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.

Authors: W L Drew; R C Miner; D F Busch; S E Follansbee; J Gullett; S G Mehalko; S M Gordon; W F Owen; T R Matthews; W C Buhles
Journal: J Infect Dis Date: 1991-04 Impact factor: 5.226

2. Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.

Authors: B S Peters; E J Beck; S Anderson; D Coleman; R Coker; J Main; C Migdal; J R Harris; A J Pinching
Journal: J Infect Date: 1991-09 Impact factor: 6.072

3. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors: S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

4. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys.

Authors: J Balzarini; L Naesens; J Slachmuylders; H Niphuis; I Rosenberg; A Holý; H Schellekens; E De Clercq
Journal: AIDS Date: 1991-01 Impact factor: 4.177

5. Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

Authors: R Pauwels; J Balzarini; D Schols; M Baba; J Desmyter; I Rosenberg; A Holy; E De Clercq
Journal: Antimicrob Agents Chemother Date: 1988-07 Impact factor: 5.191

Review 6. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

Authors: B Oberg
Journal: Pharmacol Ther Date: 1989 Impact factor: 12.310

7. Foscarnet nephrotoxicity: mechanism, incidence and prevention.

Authors: G Deray; F Martinez; C Katlama; B Levaltier; H Beaufils; M Danis; M Rozenheim; A Baumelou; E Dohin; M Gentilini
Journal: Am J Nephrol Date: 1989 Impact factor: 3.754

8. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.

Authors: C Katlama; E Dohin; E Caumes; I Cochereau-Massin; C Brancon; M Robinet; O Rogeaux; R Dahan; M Gentilini
Journal: J Acquir Immune Defic Syndr (1988) Date: 1992

9. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.

Authors: W L Drew; D Ives; J P Lalezari; C Crumpacker; S E Follansbee; S A Spector; C A Benson; D N Friedberg; L Hubbard; M J Stempien
Journal: N Engl J Med Date: 1995-09-07 Impact factor: 91.245

10. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

Authors: S A Spector; G F McKinley; J P Lalezari; T Samo; R Andruczk; S Follansbee; P D Sparti; D V Havlir; G Simpson; W Buhles; R Wong; M Stempien
Journal: N Engl J Med Date: 1996-06-06 Impact factor: 91.245

2 in total

1. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.

Authors: Ifeoma N Ude; Steven Yeh; Jessica G Shantha
Journal: Ann Eye Sci Date: 2022-03

2. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.

Authors: M N Prichard; N Gao; S Jairath; G Mulamba; P Krosky; D M Coen; B O Parker; G S Pari
Journal: J Virol Date: 1999-07 Impact factor: 5.103

2 in total